COFCO Biotechnology Co., Ltd.

000930.SZ · SHZ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & EquivalentsCN¥2,518CN¥2,388CN¥1,797CN¥1,909
Short-Term InvestmentsCN¥0CN¥0CN¥0CN¥0
ReceivablesCN¥1,392CN¥1,102CN¥1,235CN¥1,363
InventoryCN¥2,122CN¥2,814CN¥3,169CN¥2,770
Other Curr. AssetsCN¥505CN¥792CN¥668CN¥483
Total Curr. AssetsCN¥6,659CN¥7,376CN¥7,334CN¥6,810
Property Plant & Equip (Net)CN¥8,671CN¥8,551CN¥8,540CN¥8,612
GoodwillCN¥366CN¥366CN¥366CN¥366
IntangiblesCN¥629CN¥595CN¥598CN¥602
Long-Term InvestmentsCN¥457CN¥457CN¥556CN¥0
Tax AssetsCN¥291CN¥278CN¥279CN¥280
Other NC AssetsCN¥111CN¥141CN¥150CN¥659
Total NC AssetsCN¥10,525CN¥10,388CN¥10,489CN¥10,519
Other AssetsCN¥0CN¥0CN¥0CN¥0
Total AssetsCN¥17,184CN¥17,764CN¥17,823CN¥17,329
Liabilities
PayablesCN¥568CN¥785CN¥581CN¥728
Short-Term DebtCN¥2,183CN¥3,940CN¥4,618CN¥4,000
Tax PayableCN¥0CN¥83CN¥60CN¥77
Deferred RevenueCN¥217CN¥0CN¥0CN¥0
Other Curr. Liab.CN¥707CN¥354CN¥275CN¥336
Total Curr. Liab.CN¥3,903CN¥5,957CN¥6,251CN¥5,837
LT DebtCN¥1,826CN¥316CN¥176CN¥165
Deferred Rev, NCCN¥69CN¥69CN¥69CN¥70
Deferred Tax Liab, NCCN¥51CN¥56CN¥68CN¥66
Other NC Liab.CN¥73CN¥105CN¥105CN¥97
Total NC Liab.CN¥2,186CN¥721CN¥598CN¥576
Other LiabilitiesCN¥0CN¥0CN¥0CN¥0
Cap. LeasesCN¥0CN¥174CN¥180CN¥177
Total LiabilitiesCN¥6,089CN¥6,678CN¥6,849CN¥6,413
Equity
Pref StockCN¥0CN¥0CN¥0CN¥0
Common StockCN¥1,856CN¥1,860CN¥1,860CN¥1,860
Retained EarningsCN¥1,564CN¥1,592CN¥1,466CN¥1,425
AOCICN¥7,243CN¥1,320CN¥7,262CN¥0
Other EquityCN¥0CN¥0CN¥0CN¥1,317
Total EquityCN¥10,663CN¥10,685CN¥10,574CN¥10,518
Supplemental Information
Minority InterestCN¥402CN¥402CN¥400CN¥398
Total Liab. & Tot. EquityCN¥17,184CN¥17,764CN¥17,823CN¥17,329
Net DebtCN¥1,491CN¥1,868CN¥2,997CN¥2,255